HORMAD1 and breast carcinoma: Studies have shown that under the conditions of oxidative stress induced by related chemotherapy drugs, HORMAD1 may regulate the expression of enzymes in breast cancer cells to enhance the ability to resist apoptosis, which may be the main factor in inducing chemotherapy resistance.